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Abstract Pain acceptance contributes significantly to the effectiveness of pain treatment outcomes. 
Nevertheless, little research has been conducted to examine whether a decrease in acceptance 
contributes to a deterioration in post treatment functioning. The aim of this study was to assess the 
role of pain acceptance in relation to process and outcome variables in the six-months following the 
conclusion of a pain program. Adults with chronic pain (N = 120) completed assessments at the 
completion of a 3-week multidisciplinary treatment program and 6-months posttreatment. Process 
measures included the Chronic Pain Acceptance Questionnaire-8 (CPAQ-8); the catastrophizing scale 
of the Pain Response Self-Statement Scale; the coping cognitions scale of the Pain Response Self-
Statement Scale; and the Tampa Scale of Kinesiophobia. Outcome measures included the Roland 
Morris Disability Questionnaire; the depression scale of the Depression Anxiety and Stress Scale; and 
two measures of physical functioning. Deterioration in acceptance of pain was significantly 
associated with deterioration in depression and disability, even when catastrophizing cognitions and 
kinesiophobia were accounted for. Decrease in acceptance was the strongest predictor of reliable 
deterioration in depression and disability. Results indicated the CPAQ-8 has utility as a measure for 
monitoring patient functioning post-treatment. 
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Introduction 
 
Cognitive behavioral treatment for chronic pain improves depression and reduces disability (e.g., 
Morley et al., 1999; Eccleston et al., 2009; Williams et al., 2012). A number of recent studies have 
focused on change mechanisms related to these key pain treatment outcomes (e.g., Samwell et al., 
2009a, b; Turner et al., 2007; Vowles et al., 2007; Vowles et al., 2011). The aim has been to identify 
and then target the cognitive and behavioral mechanisms through psychological treatment to 
maximize treatment gains. Nevertheless, there has been little investigation of process variables (i.e., 
the underlying mechanisms of change) that contribute to deterioration in disability and depression 
after treatment completion. Identifying key post-treatment variables is important in light of findings 
that indicate adherence to cognitive behavioral therapy (CBT) techniques mastered during 
treatment (such as activity pacing and relaxation) account for only a small amount of variance in the 
maintenance of treatment gains (Curran et al., 2009; Nicholas, 2009). Curran et al. (2009) found that 
adherence to CBT techniques accounted for 3 % of the variance in changes in outcomes from the 
end of treatment to 1-month follow up. By contrast, process variables have shown robust 
associations with deterioration in mood and function after completion of treatment. 
Jensen et al. (2007) evaluated changes in coping, cognitive pain variables, disability, and depression 
from the end of treatment to 12-month follow-up. Changes in coping and cognitions were associated 
with changes in pain intensity, disability, and depression. From a traditional CBT perspective, 
cognitions are considered of primary importance as the mechanism of change in emotional disorders 
and function (Beck et al., 1979). Coping cognitions, therefore, have theoretical relevance as a 
hypothesized mechanism of change in CBT; they have also received research support as being 
relevant to chronic pain adjustment (Flor et al., 1993). As part of the fear-avoidance model of 
chronic pain, catastrophizing and kinesiophobia, have received a large volume of empirical support 
as variables linked to changes in depression and disability (Nicholas et al., 2012; Vlaeyen & Linton, 
2012). Catastrophizing refers to cognitive content characterized by magnification and rumination 
about feared outcomes (Sullivan et al., 2001). Kinesiophobia also incorporates negative expectations 
about future outcomes, but specifically relates to fear of movement (Kori et al., 1990). 
The role of deterioration in pain acceptance has not been evaluated relative to deterioration in 
outcome variables during the post-treatment period, and in particular whether it offers an additional 
novel contribution above that of established process variables (i.e., catastrophizing, kinesiophobia, 
coping cognitions). Acceptance from a behavioral perspective is an action as opposed to a cognition 
or emotion (Hayes et al., 2012). Pain acceptance is the behaviour of pursuing meaningful activities 
without avoiding pain, even when the activity brings the individual into contact with pain 
(McCracken et al., 2004). Acceptance of pain has been associated with improved depression and 
disability in cross-sectional studies (McCracken et al., 2004). Baranoff et al. (2013) previously 
identified that acceptance of chronic pain is an important process variable in traditional CBT, even 
though traditional CBT does not specifically target acceptance. Pain acceptance may also have utility 
as an indicator of deterioration in depression and disability following completion of a pain program. 
If a deterioration in acceptance is associated with functional outcomes, it will have implications for 
the type of monitoring undertaken after treatment and for the response to decline in function. 
In the present study, we evaluated 6-month changes after completion of a group-based chronic pain 
treatment that was described in Baranoff et al. (2013). Process variables (catastrophizing, 
kinesiophobia; Vlaeyen & Linton, 2012), and coping cognitions that have been established in the 
chronic pain literature (e.g., Jensen et al., 2007 and Flor et al., 1993) were considered alongside pain 
acceptance. The primary aim was to examine deterioration in pain acceptance and other process 
variables in relation to deterioration in depression and disability after completion of 
multidisciplinary treatment. We hypothesised that deterioration in acceptance would show a 
significant association with post-treatment deterioration in disability and depression, even after 
accounting for process variables previously associated with post treatment outcomes. A secondary 
focus of the study was to evaluate the utility of the recently validated 8-item short form of the 
Chronic Pain Acceptance Questionnaire (CPAQ-8; Baranoff et al., 2012; Fish et al., 2010) as a post-
treatment monitoring tool. 
 
Method 
 
Participants 
Participants in this study were 120 adults (55 % female) with chronic pain who completed end of 
program assessment and 6-month follow-up assessment, following a 3week, intensive, outpatient, 
multidisciplinary CBT-based pain management program. A total of 417 patients who attended the 
pain unit were assessed by psychologist and pain physician for suitability for group treatment. One 
hundred and ninety-seven patients commenced the program, with 187 retained by treatment 
completion. The reasons given for withdrawal from the program were family related (n = 3); 
interpersonal problems in the group (n = 2); increase in pain (n = 1); physical illness (n = 3); and 
mental health problems (n = 1). The 197 patients included the 186 who commenced treatment in 
the study described in Baranoff et al. (2013) in addition to 11 patients who were subsequently 
admitted to the group treatment program. Details of inclusion/exclusion criteria for the group 
program are described in Baranoff et al. (2013). In summary, to be included in the program, patients 
were required to be over the age of 18; have had chronic pain for over 3 months; had not responded 
to medical or surgical treatment; and had approval from their insurer for the payment of treatment 
costs. Exclusion criteria included patients who were seeking surgery, the presence of a psychotic 
disorder and patients assessed to be at risk of self-harm. Patients who had been prescribed 
medication were required to be on a stable dose prior to admission to the program. One hundred 
and twenty patients were available for the 6-month post-treatment follow-up. The mean age at end 
of the program for the 120 patients in this study was 43.1 years (SD = 9.7). 
 
A total of 34 % of the participants had not completed high school and 40 % had undertaken some 
form of training after completing high school. A total of 53 % of the participants were unemployed. 
The remainder of patients were in a work-trial or working (full-time or parttime). Mean duration of 
chronic pain was 2 years 9 months (SD = 2 years 10 months) and mean number of months since last 
participating in any type of work was 3 months (SD = 4 months). The mean self-reported usual pain 
intensity over the past week was 6 (where 0 was no pain and 10 was worst possible pain; SD = 1.7). A 
total of 51.4 % of patients were identified as having pain originating from degenerative, mechanical 
origin; 31.6 % were classified as having pain of traumatic or surgical origin; 
7.5 % of patients had pain of genetic origin; and 0.9 % had pain of primary psychological origin. The 
most-common primary region of pain was lower back, lumbar spine, sacrum, and coccyx (40.2 %). 
Other regions where pain was located were upper shoulder and limbs (15.0 %); cervical spine (10.3 
%); full body (9.3 %); head, face and mouth (8.4 %); and lower limbs (5.6 %). The most commonly 
identified primary body system associated with the pain was the musculoskeletal system and 
connective tissue (82.2 %). Other systems associated with pain included nervous system (peripheral 
and central; 9.3 %); more than one system (1.9 %); and other (0.9 %). 
 
Measures 
 
Process measures 
Acceptance of pain The Chronic Pain Acceptance Questionnaire (CPAQ-8; Fish et al., 2010), which 
consists of 8 items, was administered as part of the assessment battery. The CPAQ-8 has two 
subscales: activity engagement (e.g., 
‘‘I am getting on with the business of living no matter what my pain level is’’) and pain willingness 
(e.g., ‘‘I avoid putting myself in situations where my pain might increase’’). Questions are rated on a 
scale from 0 (never true) to 6 (always true). The internal consistency has been reported as 0.77–0.89 
(Fish et al., 2010). Cronbach’s alpha for the present study was 0.85. The validity of the CPAQ-8 has 
been demonstrated in cross-sectional studies; it shows correlations with a number of measures of 
patient-functioning (Baranoff et al., 2012; Fish et al., 2010) and predicts depression and disability, 
after accounting for catastrophizing and kinesiophobia Baranoff et al. (2012). Rodero et al. (2010) 
reported test re-test reliability of the CPAQ to be r = 0.83. 
Pain catastrophizing Pain catastrophizing was measured using the 9-item pain catastrophizing scale 
of the Pain Response Self-Statement Scale (Flor et al., 1993). The questionnaire includes items such 
as ‘‘I cannot stand this pain any longer’’. Items are rated on a 6-point scale ranging from 0 to 5; 
higher scores indicating more frequent catastrophizing when experiencing pain. The internal 
reliability of the catastrophizing scale is high (0.92 in Flor et al., 1993). Cronbach’s alpha was 0.85 in 
the present study. The test–retest reliability of the catastropizing scale was 0.77 (Flor et al., 1993). 
Kinesiophobia The Tampa Scale of Kinesiophobia is a 17 item-scale that measures fear of (re)injury 
by physical activity (Kori et al., 1990; Vlaeyen et al., 1995). Items include, ‘‘I can’t do all the things 
that normal people do because it’s too easy for me to get injured’’ and are rated on a 4-point scale 
ranging from 1 (strongly disagree) to 4 (strongly agree) with higher scores indicating higher fear of 
(re)injury. The reliability and validity of the Tampa Scale of Kinesiophobia has been established in a 
chronic-pain population (Vlaeyen et al., 1995). Cronbach’s alpha for the Tampa Scale of 
Kinesiophobia in Vlaeyen et al.’s (1995) chronic pain population was 0.77. It was 0.85 in the present 
study. The test–retest reliability of the Tampa Scale of Kinesiophobia has been reported to be 0.75 
(SwinkelsMeewisse et al., 2003). 
Pain coping Pain coping was measured using the nine items of the Pain Response Self-Statement 
Scale that relate to pain coping (Flor et al., 1993). The questionnaire lists typical coping-related 
thoughts of people in pain (e.g., ‘‘If I stay calm and relaxed, things will get better’’). Items are rated 
on a 6-point scale ranging from 0 to 5 with higher scores indicating more frequent use of coping-
related statements when experiencing pain. Cronbach’s alpha for the coping subscale of the Pain 
Response Self-Statement Scale is 0.88 (Flor et al., 1993). Cronbach’s alpha for the coping subscale of 
the Pain Response Self-Statement Scale in the present study was 0.72. The test–retest reliability of 
the coping subscale is 0.84 (Flor et al., 1993). 
 
Outcome measures 
Pain intensity Pain intensity was measured on a Numerical Rating Scale. The scale ranged from 0 (no 
pain) to 10 (worst possible pain). Ratings were given for the average daily pain in the last week. The 
Numerical Rating Scale has been shown to be a valid and sensitive measure when used to assess 
change in pain intensity (Ferreira-Valente et al., 2011). Grotle et al. (2003) reported test–retest 
reliability of pain-intensity as measured by the Numerical Rating Scale to be 0.83. 
 
Depression The depression scale of the Depression Anxiety and Stress Scale 21 contains seven items 
(Lovibond & Lovibond, 1995). The depression scale does not include somatic symptoms and is 
therefore useful in chronic-pain populations because it avoids confounding the measurement of 
depression with somatic symptoms that may relate to the pain problem. Items include ‘‘I was unable 
to become enthusiastic about anything’’ and ‘‘I felt I wasn’t worth much as a person’’. The internal 
consistency of the depression scale of the Depression Anxiety Stress Scale 21 has been shown to be 
good in a non-clinical sample (a = 0.91; Lovibond & Lovibond, 1995) and in a chronic pain sample (a = 
0.95; Nicholas et al., 2008). Cronbach’s alpha in the present study was 0.92 for the depression 
subscale. Brown et al. (1997) reported test–retest reliability of the Depression Anxiety Stress Scale 
21 depression subscale to be 0.71. 
 
Functional disability The Roland-Morris Disability Questionnaire is a 24 item-scale that measures 
functional disability (Roland & Morris, 1983). The items relate to a range of daily activities that 
patients may perceive are limited by pain. A modified version of the Roland-Morris Disability 
Questionnaire was used in this study, with references to pain in general being substituted for 
references to a specific injury site (e.g., ‘‘Because of my back, I lie down to rest more often’’), to be 
suitable for use with all pain locations. The reliability and validity of the modified measure has been 
established in a chronic-pain population with an internal reliability of 0.92 (Asghari & Nicholas, 
2001). Cronbach’s alpha for the modified Roland-Morris Disability Questionnaire in the present 
study was 0.83. Asghari (2011) reported test–retest reliability of the modified Roland-Morris 
Disability Questionnaire to be 0.90. 
 Physical measures The timed-walked was conducted over 5-minutes. The walk was conducted in an 
empty corridor with permanent marks placed 20 meters apart. The timed-walk has been shown to 
have good inter-rater reliability in a chronic-pain population; it has also demonstrated sensitivity to 
change in functioning during treatment (Harding et al., 1994). The test–retest reliability of the 
measure is 0.94 (Harding et al., 1994). 
The sit-to-stand task was conducted in a chair without armrests. Patients were not permitted to use 
their arms to assist them (Harding et al., 1994). Patients were instructed to perform as many sit-to-
stand actions as they could in 1 min and were given a reminder at 30 s. The sit-to-stand test has 
been shown to have good inter-rater reliability in a chronicpain population and to be sensitive to 
change in function during treatment (Harding et al., 1994). The test–retest reliability of the measure 
is 0.84 (Harding et al., 1994). 
  
Procedure 
The group treatment program is described in Baranoff et al. (2013). In summary, the study was 
conducted in a public hospital outpatient pain-clinic. Treatment consisted of a manualized CBT based 
on Nicholas et al. (2007). The treatment team was multidisciplinary; sessions were conducted with a 
physiotherapist, psychologist, pain physician and nurse. The activity component of the program 
consisted of graded exposure invivo to activities that the patient avoided and graded activity as 
usual. The rationale for the exposure component of the program was based on the fearavoidance 
model (Vlaeyen & Linton, 2012). The psychological component of the course was based on 
traditional CBT; it consisted of cognitive restructuring, relaxation training, goal setting, and 
education regarding chronic pain. Questionnaires were completed at the end of the program. 
Follow-up questionnaires were mailed out to participants just prior to 6 months after completion of 
the program. Participants were invited to attend the clinic in person at 6month follow-up to return 
completed questionnaires and so that physical measures could be administered. Ethical clearance 
was obtained from both a hospital and university ethics review committee. Patients provided 
written consent. 
 
 
Data analytic strategy 
T-tests were performed to assess changes from pre-treatment to end of treatment and from end of 
treatment to 6-month follow-up. Effect sizes were then calculated using the formula described by 
Dunlap et al. (1996). This formula accounts for the correlation between preand posttreatment 
scores. 
Next, residualized change scores were calculated and linear regressions conducted to assess the 
relationship between changes in process measures and changes in outcome measures. Four process 
measures (changes in pain acceptance, kinesiophobia, coping cognitions, and catastrophizing 
cognitions) were entered into regression models as a block; separate regressions were conducted 
using change in depression and then change in disability as the criterion. Regressions were 
conducted with the focal process variable, acceptance, measured using the CPAQ-8. 
Reliable change index (Jacobson & Truax, 1991) scores were calculated for all process and outcome 
variables. An alpha of 0.05 (corresponding to the 95 % confidence interval) was used to determine 
the criterion to assess the reliability of individual level change. This type of analysis is in accordance 
with suggestions made by Wise (2004) and Morley (2011). 
The patient was considered to have experienced reliable change on a measure if their score changed 
by an amount greater than the calculated criterion. The Reliable Change Index was determined by 
first calculating a standard error of difference that was then used to calculate confidence intervals to 
assess measurement error. For each outcome measure, comparisons were made between an 
individual’s change score and the criterion score for reliable change, resulting in the identification of 
three groups based on the direction of therapeutic change (patients who showed deterioration, 
those who stayed the same, and those who showed improvement). Next, logistic regressions were 
conducted using demographic and end of treatment variables as predictors of reliable deterioration 
in disability, depression and of reliable deterioration in depression and/ or disability. The dependent 
variables used in the logistic regressions were dichotomous variables. Finally, residualized change 
scores of process variables (from end of treatment to 6-months) were entered as predictors to 
evaluate the relationship between process variables and reliable change in disability, depression, 
and in depression and/or disability. 
 
 
Results 
 
Preliminary analyses 
The data revealed no univariate or multivariate outliers, and no multicolinearity. Examination of 
residuals scatterplots showed that the data met assumptions for normality, linearity, and 
homoscedacity. At post-treatment, there were no statistically significant differences on key variables 
(age, gender, pain-intensity, duration of pain, time since last worked, depression, anxiety, disability, 
acceptance, and catastrophizing) between patients who completed the 6-month follow-up 
questionnaire and individuals who did not complete the 6-month follow-up questionnaire; For pre-
treatment scores, all ts(195) \ 1.13, all ps [ .26, expect for sit-stand which showed a statistically 
significant difference at pre-treatment between the group that completed the 6-month 
questionnaire and those that did not, t(195) = 2.47, p \ .05. For post-treatment, all ts(185) \ 1.97, all 
ps [ .05. The 120 cases and 4 independent variables yielded a cases-to-IV ratio of 30:1, which is 
above the minimum requirement for regression. 
 
End of treatment/6-month follow-up changes 
Table 1 shows the means and standard deviations of measures at pre-treatment, end of treatment 
and 6-month follow-up for the 120 patients. Changes between end of treatment and 6-month 
follow-up were statistically significant for all variables except pain intensity and timed walk; all other 
ts(119) [ 1.98, all other ps B .05. Table 1 (right half) shows the effect sizes for all measures from 
pretreatment to end of treatment and from end of treatment to 
6-month follow-up. From pre-treatment to end of treatment, the average effect size was 0.72 (range 
0.58–0.97) for process variables and 0.46 (range 0.11–0.78) for outcome variables. From end of 
treatment to 6-month follow up, the average effect size was -0.31 (range -0.19 to -0.50) for process 
variables and -0.18 (range \-0.1 to -0.37) for outcome variables. 
  
 
Table 1 Means (SD) of process variables and outcome variables at pre-treatment, post-treatment 
and 6-month Follow-up 
Table 2 Correlations between changes in process and outcome measures 
Table 3 Multiple regressions predicting post-treatment change in outcome measures from change in 
coping beliefs, catastrophizing, 
 
End of treatment to 6-month follow-up process analysis 
Table 2 shows the Pearson product-moment coefficients for correlations between residualized 
changes in processvariables (measured from end of treatment to 6-month follow-up) and 
residualized changes in outcome variables (measured from end of treatment to 6-month follow-up). 
From end of treatment to 6-month follow-up, 11 of the 20 correlations between changes in process 
measures and changes in outcome measures were significant. The correlations between the process 
measures were not sufficiently high (r \ 0.53) to raise concern about multicollinearity in subsequent 
regression analyses. 
Table 3 shows the concurrent validity of change in acceptance, kinesiophobia, catastrophizing, and 
coping cognitions. The criterion variables were change in depression and disability. Analyses were 
not conducted with change in pain-intensity and timed walk because these outcomes did not show 
significant change from end of treatment to 6-month follow up. Change in sit-stand was not 
considered as a criterion measure in the process analysis because it did not correlate with any 
process measures. All process variables entered simultaneously predicted 
38 % (R2 0.38, p \ .001) of variance in change in depression and accounted for 32 % (R2 0.32, p \ 
.001) of variance in change in disability. The process variables of catastrophizing (b = 0.35), 
kinesiophobia (b = -0.26), and acceptance (b = -0.44) were statistically significant unique predictors 
of change in depression; kinesiophobia (b = 0.31) and acceptance (b = -0.22) were statistically 
significant predictors of changes in disability. 
 
Reliable change analyses 
Table 4 contains the reliable change scores for all process measures and outcome measures. A 95 % 
confidence interval (a = 0.05) was used to calculate the criterion values to assess reliable change in 
each measure as described by Jacobson and Truax (1991). To make comparisons between variables, 
deterioration was defined as change in the direction associated with decreased adjustment in 
chronic pain as classified in previous research and included decrease in acceptance, increase in 
catastrophizing, increase in kinesiophobia, decrease in coping cognitions, increase in depression, and 
increase in disability. The average proportion of patients who had experienced reliable deterioration 
was 24.1 % across all measures (range 15–35.8 %). Of the 
120 participants, 33.3 % (n = 40) had reliably deteriorated in either depression and disability. This 
indicates that for one person to see a reliable deterioration in depression or disability, 3 patients 
(i.e., 120/40) would need to go through the 6-month post-treatment period. A total of 5 patients 
(i.e., 
120/24) would need to go through the 6-month post treatment period to see a reliable deterioration 
in depression for one patient. A total of 4.3 patients (i.e., 120/28) would need to go through the 6-
month post treatment period to see a reliable deterioration in disability for one patient. 
 
Logistic regressions predicting reliable deterioration in functioning 
Given the importance of depression and disability as outcomes in chronic pain treatment, as 
documented in a recent Cochrane Review (Williams et al., 2012), reliable change categories of these 
measures were used as outcomes in logistic regression analysis. In addition to considering reliable 
change in these variables individually, a composite measure of reliable post-treatment deterioration 
was developed. A similar approach has been used to create dichotomous dependent variables to 
measure treatment response in studies evaluating effectiveness and processes of change (e.g., 
Vowles et al., 2011). In the present study, patients were considered to have experienced reliable 
post-treatment deterioration in clinically relevant outcomes when they experienced reliable 
deterioration in depression and/or disability. 
First, logistic regressions were run with demographic variables (age, gender, duration of pain, 
highest level of education) and post-treatment scores as the predictor variables and reliable changes 
in disability, depression and depression and/or disability as the outcome measures. The model 
containing demographic and post-treatment scores was not statistically significant for any of the 
three dependent variables, indicating that the model was not able to distinguish between patients 
who did and did not experience a reliable deterioration in measures of disability (v2(11, N = 120) = 
10.6, p = .48); depression (v2(11, N = 120) = 7.8, p = .73) and, disability and/or depression, (v2 (11, N 
= 120) = 7.7, p = .74). 
Second, a logistic regression was performed to assess the impact of change in process variables on 
the likelihood that patients would experience reliable deterioration in depression. The model 
consisted of four independent variables (changes in coping cognitions, acceptance, catastrophizing 
cognitions, and kinesiophobia). The model containing all four change variables as predictors was 
statistically significant (v2 (4, N = 120) = 29.1, p = .001), which indicated that the model was able to 
distinguish between patients who reliably deteriorated in disability over the 6-month post treatment 
period and those who did not. The Cox and Snell R square was .31 and the Nagelkerke R Square was 
.49. The model correctly classified 88.8 % of cases. As can be seen in Table 5 (top section), change in 
CPAQ-8, in addition to changes in catastrophizing and kinesiophobia, made a significant contribution 
to the model. 
Third, a logistic regression was performed to assess the impact of change in process variables on the 
likelihood that patients would experience reliable deterioration in disability. The model again 
consisted of four independent variables (changes in coping cognitions, acceptance, catastrophizing 
cognitions, and kinesiophobia). The model containing all four change variables as predictors was 
statistically significant (v2 (4, N = 120) = 14.0, p = .001), which indicated that the model was able to 
distinguish between patients who reliably deteriorated in disability over the 6-month post treatment 
period and those who did not. The Cox and Snell R square was .14 and the Nagelkerke R Square was 
.22. The model correctly classified 77.7 % of cases. As can be seen in Table 5 (middle section), only 
change in CPAQ-8 made a significant contribution to the model. 
Finally, logistic regression was performed to assess the impact of change in process variables on the 
likelihood that patients would experience a reliable deterioration in a composite of depression and 
disability (i.e., change in either depression and/or disability). The model consisted of four 
independent variables (changes in coping cognitions, acceptance, catastrophizing cognitions, and 
kinesiophobia). The model containing all four change variables as predictors was statistically 
significant (v2 (4, N = 120) = 19.7, p = .001), which indicated that the model was able to distinguish 
between patients who reliably deteriorated in depression and/or disability over the 6-month post 
treatment period and those who did not. The Cox and Snell R square was .19 and the Nagelkerke R 
Square was .26. The model correctly classified 75.8 % of cases. As can be seen in Table 5 (bottom 
section), only change in CPAQ-8 made a significant contribution to the model. 
 
 
Discussion 
The results of this study indicate that the Chronic Pain Acceptance Questionnaire-8 (CPAQ-8) is 
sensitive to post-treatment change in pain acceptance and has clinical utility to track post-treatment 
progress. Changes in pain acceptance, catastrophizing, and kinesiophobia all showed statistically 
significant associations with changes in depression, from end of treatment to 6-months follow-up. 
Further, pain acceptance and kinesiophobia were significantly associated with change in disability. 
Change in pain acceptance was the only significant predictor of reliable change (as measured by the 
Reliable Change Index; Jacobson & Truax, 1991) in depression and/or disability, among a number of 
empirically supported process variables. 
This study demonstrated that the CPAQ-8 may be used to effectively track patient progress after 
treatment completion with low response burden. Furthermore, the findings support the notion that 
maintaining levels of pain acceptance (namely behaviours associated with activity engagement and 
pain willingness) may lessen deterioration in depression and disability in follow up. Consequently, 
treatment approaches that produce enduring patterns of activity engagement and pain willingness 
may produce good long-term outcomes. 
The focus of this study was to assess the use of the CPAQ-8 as an indicator of deterioration in 
depression and disability following multidisciplinary pain treatment. Nevertheless, the study 
highlighted that, in addition to changes in acceptance of pain, changes in catastrophizing and 
kinesiophobia were also associated with changes in depression, and change in kinesiophobia was 
associated with change in disability. These findings support previous research that has linked 
catastrophizing with depression (Esteve et al., 2007; Flor et al., 1993), and kinesiophobia with 
disability (Vlaeyen & Linton, 2012). Further, catastrophizing and kinesiophobia have been shown to 
be associated with future sick-leave and dysfunction in a longitudinal sample (Westman et al., 2011). 
Pain acceptance appears to play an equally important and unique role as a process variable in the 6 
months following treatment. The CPAQ-8 adds incremental validity to the assessment of processes 
of change in the post-treatment period, even when catastrophizing, kinesiophobia and coping 
cognitions are assessed. 
This study has both theoretical and assessment implications. Pain acceptance was not targeted in 
the traditional CBT program. Nevertheless, as reported in Baranoff et al. (2013), pain acceptance did 
increase in response to traditional CBT treatment and was uniquely associated with changes in 
outcomes, even after accounting for change in catastrophizing. We considered the exposure based 
treatment and goal setting of the traditional CBT program to include pain acceptance as an implicit 
component. The key role that pain acceptance plays in both acceptance-based treatment and 
traditional CBT has now been demonstrated in a number of comparison studies (e.g., Vowles et al., 
2009; Wetherell et al., 2011) and uncontrolled studies (e.g., Baranoff et al., 2013; Vowles et al., 
2007). Therefore, monitoring acceptance during traditional CBT programs and acceptance-based 
programs has utility. The present study extends the literature by examining whether the recently 
developed CPAQ-8 has utility in the post-treatment period relative to a broad range of process 
variables that have been supported. This study provided support for the CPAQ-8¢s sensitivity to 
change and unique relationship with outcome variables in the 6-months post treatment, even when 
process measures from traditional CBT were assessed. The CPAQ-8 holds promise as a brief measure 
to detect decline in functioning following treatment. From a theoretical perspective, this study 
highlights that pain acceptance plays a key role as a process variable in the 6months following the 
completion of a traditional CBT pain program. 
This study has some limitations. First, the outcome variables were determined by standardised self-
report questionnaires. Although widely used in pain research, they remain proxy measures of 
functioning. Second, process measures and outcomes were assessed concurrently; therefore, 
statements of causation are not possible. Third, although follow-up retention was high and only one 
difference was identified on process or outcomes measures between those that completed the 6-
month follow-up and those that did not, it is possible that retained patients represented a better 
functioning group. 
In future research, the direction of the relationship between process and outcome could be 
examined by employing designs that incorporate random allocation of patients to treatment and a 
comparison or control group. The design would be further improved by collecting data over more 
than two data points and by using methods such as cross-lagged panel correlation (Kenny, 1975). 
Crosslagged panel correlation analysis has been used to compare early treatment changes to late 
treatment changes over the intervention period for chronic pain treatment (see Burns et al., 2003a 
& b). In this study, we were primarily interested in the changes that occur after the completion of 
the program. In order to carry out a causal analysis of process variables in the post-treatment 
period, identification of the appropriate time-frame to detect post-treatment deterioration in 
process variables and then in outcome variables is required. Future research could also investigate 
whether the CPAQ-8 is suitable to use in intensive data sampling to determine the individual 
trajectories of patients who deteriorate after the completion of treatment (see Tang & DeRubeis, 
1999). This approach has been used in the psychotherapy literature but has not been extensively 
applied to chronic pain treatment. Repeated sampling may include completion of the CPAQ-8 on a 
weekly or session by session basis. The CPAQ-8’s sensitivity to detect such changes requires further 
investigation. Clinically, a patient’s departure from the expected progress trajectory could be used as 
a signal to commence further intervention. Treatment booster sessions that focus on relevant 
processes could be initiated for individuals who show deterioration in pain acceptance. The use of 
single case designs may also highlight the patterns of deterioration and response to booster sessions 
more clearly (Moran and Tai, 2001). It remains unclear whether changes post-treatment differ 
according to whether the treatment is acceptance-based or traditional CBT. Group level comparison 
is unlikely to clarify this issue fully because there may be moderating factors that affect the 
durability of response to particular treatments. Further analysis of individual deterioration of 
function following both acceptance-based and traditional CBT is required. This study emonstrated 
that using a 95 % confidence interval for RCIs provided sufficient sensitivity to detect change at the 
individual level in the 6 months post-treatment. 
In summary, change in acceptance of pain was a strong predictor of change in depression and 
disability following pain treatment, even after accounting for changes in painrelevant cognitions. 
Pain acceptance provides clinically relevant information in the post treatment period, either as a 
measure used alone or as part of a broader assessment approach. 
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